119 results
DEFA14A
MGTX
MeiraGTx Holdings plc
25 Apr 24
Additional proxy soliciting materials
8:38am
Materials
Soliciting Material under §240.14a-12
MeiraGTx Holdings plc
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy … Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
No fee required.
Fee paid previously with preliminary materials
8-K
EX-99.1
MGTX
MeiraGTx Holdings plc
14 Mar 24
MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates
9:16am
; contamination or shortage of raw materials or other manufacturing issues; changes in healthcare laws; risks associated with our international
8-K
EX-99.1
cfn0fn1 0j
13 Feb 24
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals
8:10am
8-K
7s4nlrbkwqnrp
21 Dec 23
MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million
7:10am
8-K
EX-99.1
isxlk990c51gglgs8dt
21 Dec 23
MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million
7:10am
8-K
EX-99.1
003r0p7kjne
14 Nov 23
MeiraGTx Announces Third Quarter 2023 Financial and Operational Results
12:00am
8-K
EX-10.1
8f4p8
30 Oct 23
Company Pursuing Multiple Additional Strategic Opportunities
7:37am
8-K
EX-99.1
l497dah
30 Oct 23
Company Pursuing Multiple Additional Strategic Opportunities
7:37am
8-K
EX-99.1
4gtb0ffri
10 Aug 23
MeiraGTx Reports Second Quarter 2023 Financial and Operational Results
8:13am
8-K
EX-99.1
swkbuf
11 May 23
MeiraGTx Reports First Quarter 2023 Financial and Operational Results
8:12am
DEFA14A
rw4bi
27 Apr 23
Additional proxy soliciting materials
8:48am